Skip to main content
Journal cover image

Severe Persistent Pain and Inflammatory Biomarkers in Sickle Cell Disease: An Exploratory Study.

Publication ,  Journal Article
Knisely, MR; Tanabe, PJ; Walker, JKL; Yang, Q; Shah, NR
Published in: Biol Res Nurs
January 2022

BACKGROUND: Severe pain is among the most common and deleterious symptoms experienced by individuals with sickle cell disease (SCD), of whom more than 50% report chronic pain. Despite this, the understanding of the biological contributors to persistent severe SCD pain is limited. This exploratory study sought to describe pain phenotypes based on frequency of severe pain experienced over 6 months and identify inflammatory biomarkers associated with pain phenotypes among individuals with SCD. METHODS: This study used self-report and electronic health record data collected from 74 individuals enrolled in the Duke Sickle Cell Disease Implementation Consortium Registry. Plasma from previously collected blood specimens was used to generate inflammatory biomarker data using the Inflammation 20-plex ProcartaPlexTM panel. Descriptive statistics were used to describe the occurrence of severe pain over the past 6 months, and bi-variate analyses were used to evaluate the relationship between inflammatory biomarkers and pain phenotypes. RESULTS: Among the 74 participants included in this study, 33.8% reported severe pain occurring never or rarely, 40.5% reported severe pain occurring sometimes, and 25.7% reported severe pain occurring often or always. Soluble E-selectin (sE-selectin) was the only inflammatory biomarker significantly associated with the pain phenotype groups (p = 0.049). Post hoc comparisons identified that participants in the often/always severe pain group had significantly higher plasma concentrations of sE-selectin compared to those in the sometimes severe pain group (p = 0.040). CONCLUSIONS: Our findings provide preliminary evidence of the frequent occurrence of severe pain and that sE-selectin may be an objective biomarker for the frequent occurrence of severe pain in this population.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Biol Res Nurs

DOI

EISSN

1552-4175

Publication Date

January 2022

Volume

24

Issue

1

Start / End Page

24 / 30

Location

United States

Related Subject Headings

  • Self Report
  • Selectins
  • Pain
  • Nursing
  • Humans
  • Biomarkers
  • Anemia, Sickle Cell
  • 4205 Nursing
  • 1110 Nursing
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Knisely, M. R., Tanabe, P. J., Walker, J. K. L., Yang, Q., & Shah, N. R. (2022). Severe Persistent Pain and Inflammatory Biomarkers in Sickle Cell Disease: An Exploratory Study. Biol Res Nurs, 24(1), 24–30. https://doi.org/10.1177/10998004211027220
Knisely, Mitchell R., Paula J. Tanabe, Julia K. L. Walker, Qing Yang, and Nirmish R. Shah. “Severe Persistent Pain and Inflammatory Biomarkers in Sickle Cell Disease: An Exploratory Study.Biol Res Nurs 24, no. 1 (January 2022): 24–30. https://doi.org/10.1177/10998004211027220.
Knisely MR, Tanabe PJ, Walker JKL, Yang Q, Shah NR. Severe Persistent Pain and Inflammatory Biomarkers in Sickle Cell Disease: An Exploratory Study. Biol Res Nurs. 2022 Jan;24(1):24–30.
Knisely, Mitchell R., et al. “Severe Persistent Pain and Inflammatory Biomarkers in Sickle Cell Disease: An Exploratory Study.Biol Res Nurs, vol. 24, no. 1, Jan. 2022, pp. 24–30. Pubmed, doi:10.1177/10998004211027220.
Knisely MR, Tanabe PJ, Walker JKL, Yang Q, Shah NR. Severe Persistent Pain and Inflammatory Biomarkers in Sickle Cell Disease: An Exploratory Study. Biol Res Nurs. 2022 Jan;24(1):24–30.
Journal cover image

Published In

Biol Res Nurs

DOI

EISSN

1552-4175

Publication Date

January 2022

Volume

24

Issue

1

Start / End Page

24 / 30

Location

United States

Related Subject Headings

  • Self Report
  • Selectins
  • Pain
  • Nursing
  • Humans
  • Biomarkers
  • Anemia, Sickle Cell
  • 4205 Nursing
  • 1110 Nursing